About: Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $0.88 (-7.09%)
CRDL NASDAQ Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc Class A share price
CRDL price activity
Last Price
$0.880
Change (24hr)
-0.07 USD (7.09%)
Volume
932.90K
Volume (4w avg)
-
Open
$0.95
Day Range
$0.87 - $0.95
Previous Close
$0.95
Last Trade
19 Nov, 9:00 pm GMT+0
Delayed
19 Nov, 9:00 pm GMT+0
CRDL price performance
Delayed
19 Nov, 9:00 pm GMT+0
CRDL details
CRDL Market Signals